Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sean Tu

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|December 16, 2024
Use of Public Research and Manufacturing Enterprises to Lower Prescription Drug Prices and Increase InnovationAlex Moss, Dana Brown, S Sean Tu
JAMA|January 13, 2023
Recent Patent Reform Bills and Their Implications for Prescription DrugsS Sean Tu, Sarosh Nagar, Aaron S Kesselheim
JAMA|August 12, 2024
Extent of Drug Patents With Terminal Disclaimers and Obviousness-Type Double Patenting RejectionsS Sean Tu, Aaron S Kesselheim, Bernard Chao
The New England Journal of Medicine|January 3, 2025
Leveraging Old Hepatitis C TherapiesS Sean Tu, Shyamasundaran Kottilil, T Joseph Mattingly
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|April 28, 2025
Certification Marks for Supporting Generic Drug QualityLars Lindgren, Aaron S Kesselheim, S Sean Tu
Health Affairs Scholar|November 24, 2025
Recent changes in discretionary denials of drug patent challengesS Sean Tu, Arti Rai, Aaron S Kesselheim
JAMA|November 13, 2023
Ancillary Product Patents to Extend Biologic Patent LifeRachel Goode, William B Feldman, S Sean Tu
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|September 16, 2025
Overlapping Method of Use Patents to Prevent Generic EntryJin Park, Aaron S Kesselheim, S Sean Tu
JAMA|December 14, 2023
Biologic Patent Thickets and Terminal DisclaimersS Sean Tu, Rachel Goode, William B Feldman
IEEE Pulse|October 27, 2022
Antibody Patent EvolutionTheodore W Teng, Aaron S Kesselheim, S Sean Tu
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|December 16, 2024
Use of Public Research and Manufacturing Enterprises to Lower Prescription Drug Prices and Increase InnovationAlex Moss, Dana Brown, S Sean Tu
JAMA|January 13, 2023
Recent Patent Reform Bills and Their Implications for Prescription DrugsS Sean Tu, Sarosh Nagar, Aaron S Kesselheim
JAMA|August 12, 2024
Extent of Drug Patents With Terminal Disclaimers and Obviousness-Type Double Patenting RejectionsS Sean Tu, Aaron S Kesselheim, Bernard Chao
The New England Journal of Medicine|January 3, 2025
Leveraging Old Hepatitis C TherapiesS Sean Tu, Shyamasundaran Kottilil, T Joseph Mattingly
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|April 28, 2025
Certification Marks for Supporting Generic Drug QualityLars Lindgren, Aaron S Kesselheim, S Sean Tu
Health Affairs Scholar|November 24, 2025
Recent changes in discretionary denials of drug patent challengesS Sean Tu, Arti Rai, Aaron S Kesselheim
JAMA|November 13, 2023
Ancillary Product Patents to Extend Biologic Patent LifeRachel Goode, William B Feldman, S Sean Tu
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|September 16, 2025
Overlapping Method of Use Patents to Prevent Generic EntryJin Park, Aaron S Kesselheim, S Sean Tu
JAMA|December 14, 2023
Biologic Patent Thickets and Terminal DisclaimersS Sean Tu, Rachel Goode, William B Feldman
IEEE Pulse|October 27, 2022
Antibody Patent EvolutionTheodore W Teng, Aaron S Kesselheim, S Sean Tu
Pageof 6